Correlation Between Angel Oak and Franklin Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Angel Oak and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Angel Oak and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Angel Oak Ultrashort and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Angel Oak and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Angel Oak with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Angel Oak and Franklin Biotechnology.

Diversification Opportunities for Angel Oak and Franklin Biotechnology

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Angel and Franklin is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Angel Oak Ultrashort and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Angel Oak is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Angel Oak Ultrashort are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Angel Oak i.e., Angel Oak and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Angel Oak and Franklin Biotechnology

Assuming the 90 days horizon Angel Oak Ultrashort is expected to generate 0.08 times more return on investment than Franklin Biotechnology. However, Angel Oak Ultrashort is 12.64 times less risky than Franklin Biotechnology. It trades about 0.15 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about -0.04 per unit of risk. If you would invest  974.00  in Angel Oak Ultrashort on September 3, 2024 and sell it today you would earn a total of  9.00  from holding Angel Oak Ultrashort or generate 0.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Angel Oak Ultrashort  vs.  Franklin Biotechnology Discove

 Performance 
       Timeline  
Angel Oak Ultrashort 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Angel Oak Ultrashort are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Angel Oak is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Franklin Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Franklin Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Angel Oak and Franklin Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Angel Oak and Franklin Biotechnology

The main advantage of trading using opposite Angel Oak and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Angel Oak position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.
The idea behind Angel Oak Ultrashort and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope